样本量较小与AAOS前交叉韧带损伤临床实践指南引用的随机对照试验中伤害报告率较低相关
本研究评估了美国骨科医师学会(AAOS)前交叉韧带损伤临床实践指南引用的116项随机对照试验(RCT)对CONSORT伤害扩展清单18个条目的依从性。平均依从9.25项(51.4%),样本量>500例的研究依从性显著高于<50例的研究(P=0.046),资金来源披露和盲法实施与依从性无显著差异。
要点
- 116项RCT平均仅报告9.25/18项(51.4%)CONSORT伤害条目,变异较大。
- 样本量>500例的研究依从性显著高于<50例的研究(P=0.046)。
- 资金来源披露和盲法实施与报告依从性无显著差异(P=0.85和P=0.37)。
核心结论
- AAOS前交叉韧带损伤指南引用的RCT平均仅依从51.4%的CONSORT伤害清单条目,研究间变异较大,报告实践有待改进以支持循证治疗决策。
研究设计与样本
- 横断面研究,纳入AAOS前交叉韧带损伤管理临床实践指南引用的116项随机对照试验,评估其对CONSORT伤害扩展清单18个条目的依从性。
主要发现
- 平均依从9.25/18项(51.4%),依从性最高的研究满足15/18项(83.3%),最低的满足3/18项(16.7%)。
- 18项RCT(15.5%)报告了≤33%的条目,22项RCT(19.0%)报告了≥67%的条目。
- 样本量>500例的研究依从性显著高于<50例的研究(P=0.046)。
- 资金来源披露(P=0.85)和盲法实施(P=0.37)与依从性无显著差异。
- 中断时间序列回归分析显示,2004年清单发布前后报告率均无显著变化(发布前R²=0.017,P=0.62;发布后R²=0.21,P=0.16)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Randomized controlled trials (RCTs) significantly influence clinical decision-making, necessitating comprehensive reporting of trial outcomes. However, previous studies have demonstrated that reporting of harms among RCTs is often inadequate. PURPOSE/HYPOTHESIS: The purpose of this study was to evaluate reporting of harms among RCTs cited within the American Academy of Orthopaedic Surgeons (AAOS) clinical practice guidelines (CPGs) for anterior cruciate ligament (ACL) injuries, with an emphasis on study characteristics associated with adherence. We hypothesized that >50% of these trials would have incomplete adherence to the checklist items outlined in the Consolidated Standards of Reporting Trials (CONSORT) extension for harms and that a larger sample size would be associated with greater compliance. STUDY DESIGN: Cross-sectional study. METHODS: We identified RCTs cited in the AAOS CPGs for the management of ACL injuries and assessed compliance with the 18-item CONSORT extension for harms checklist. Descriptive statistics were used to summarize overall adherence to the checklist items, and linear regression analysis evaluated adherence over time. RESULTS: Our analysis included 116 RCTs, the majority of which were single-center studies (81.0%). Most trials had sample sizes of 50-100 patients (45.7%) or 101-500 patients (37.9%). On average, trials adhered to 9.25 of 18 CONSORT items (51.4%), with the most compliant study meeting 15 of 18 items (83.3%) and the least compliant meeting 3 of 18 items (16.7%). Overall, 18 RCTs (15.5%) reported ≤33% of items, and 22 RCTs (19.0%) reported ≥67% of items. Studies with >500 patients had significantly higher adherence compared with studies with <50 patients (P = .046). There was no significant difference in adherence based on the disclosure of funding sources (P = .85) or the implementation of blinding (P = .37). Interrupted time series regression analysis demonstrated no significant change in reporting both before (R2 = 0.017; P = .62) and after (R2 = 0.21; P = .16) the release of the checklist in 2004. CONCLUSION: On average, RCTs cited within the AAOS CPGs for the management of ACL injuries adhered to 51.4% of CONSORT checklist requirements, with considerable variability across studies. Improvements in reporting practices are warranted to support evidence-based treatment decisions.
引用
- Stadler RD, Terrany R, Sudah SY, et al. A Smaller Sample Size Is Associated With Lower Rates of Reporting of Harms in Randomized Controlled Trials Cited in the AAOS Clinical Practice Guidelines for Anterior Cruciate Ligament Injuries. Am J Sports Med. 2025. PMID: 40091163. doi:10.1177/03635465251321100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。